GNFT Genfit SEC filings

6-K

GNFT Genfit

13 Jan 21

Current report (foreign)

6-K

GNFT Genfit

12 Jan 21

Current report (foreign)

6-K

GNFT Genfit

8 Jan 21

Current report (foreign)

6-K

GNFT Genfit

6 Jan 21

GENFIT to Present at Upcoming Investor Conferences and Host a PBC KOL Event

6-K

GNFT Genfit

22 Dec 20

Current report (foreign)

6-K

GNFT Genfit

7 Dec 20

Current report (foreign)

6-K

GNFT Genfit

7 Dec 20

GENFIT announces the successful completion of a key milestone

6-K

GNFT Genfit

30 Nov 20

GENFIT announces satisfactory preliminary results of its OCEANEs’ partial buyback offer

6-K

GNFT Genfit

23 Nov 20

GENFIT Announces Final Terms For Proposed Renegotiation of

6-K

GNFT Genfit

16 Nov 20

Current report (foreign)

6-K

GNFT Genfit

16 Nov 20

Current report (foreign)

6-K

GNFT Genfit

1 Oct 20

Current report (foreign)

6-K

GNFT Genfit

30 Sep 20

Current report (foreign)

6-K

GNFT Genfit

28 Sep 20

GENFIT and LabCorp Sign Exclusive Agreement to Commercialize a Novel Diagnostic Test for Liver Disease

6-K

GNFT Genfit

24 Sep 20

GENFIT Announces First Patient First Visit for ELATIVE Phase 3 Study Evaluating Elafibranor in PBC

6-K

GNFT Genfit

22 Sep 20

Current report (foreign)

6-K

GNFT Genfit

5 Aug 20

GENFIT Announces Pivotal Publication of NIS4™ Technology to Identify Patients with At-Risk NASH in The Lancet Gastroenterology & Hepatology

6-K

GNFT Genfit

22 Jul 20

Current report (foreign)

6-K

GNFT Genfit

7 Jul 20

Current report (foreign)

6-K

GNFT Genfit

30 Jun 20

Current report (foreign)